Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gloria Bachmann

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Contraception|May 7, 2013
Practice of and attitudes towards family planning among South Asian American immigrantsHuma Farid, Shazia Mehmood Siddique, Gloria Bachmann, et al.
The Clinical Journal of Pain|November 15, 2016
Recommendations for Self-Report Outcome Measures in Vulvodynia Clinical TrialsCaroline F Pukall, Sophie Bergeron, Candace Brown, et al.
Maturitas|June 15, 2017
Assessing the thickness of the vaginal wall and vaginal mucosa in pre-menopausal versus post-menopausal women by transabdominal ultrasound: A feasibility studyAdrian Balica, Daniella Wald-Spielman, Katherine Schertz, et al.
Menopause (New York, N.Y.)|February 4, 2011
Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trialGloria Bachmann, Uel Crosby, Robert A Feldman, et al.
Journal of Lower Genital Tract Disease|August 5, 2014
Milnacipran in provoked vestibulodynia: efficacy and predictors of treatment successCandace Brown, Gloria Bachmann, David Foster, et al.
Maturitas|May 13, 2015
The exercise prescription for enhancing overall health of midlife and older womenMiriam J Woodward, Chi Wei Lu, Richard Levandowski, et al.
The Journal of Reproductive Medicine|September 14, 2006
Subjective and objective outcomes of botulinum toxin type A treatment in vestibulodynia: pilot dataCandace S Brown, Howard I Glazer, Val Vogt, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 1, 2011
Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studiesLeena Anttila, Gloria Bachmann, László Hernádi, et al.
Contraception|August 25, 2004
Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenoneGloria Bachmann, Patricia J Sulak, Carole Sampson-Landers, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|January 10, 2009
Continued symptom improvement in sexually active women with overactive bladder and urgency urinary incontinence treated with tolterodine ER for 6 monthsRebecca G Rogers, Tola Omotosho, Gloria Bachmann, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Contraception|May 7, 2013
Practice of and attitudes towards family planning among South Asian American immigrantsHuma Farid, Shazia Mehmood Siddique, Gloria Bachmann, et al.
The Clinical Journal of Pain|November 15, 2016
Recommendations for Self-Report Outcome Measures in Vulvodynia Clinical TrialsCaroline F Pukall, Sophie Bergeron, Candace Brown, et al.
Maturitas|June 15, 2017
Assessing the thickness of the vaginal wall and vaginal mucosa in pre-menopausal versus post-menopausal women by transabdominal ultrasound: A feasibility studyAdrian Balica, Daniella Wald-Spielman, Katherine Schertz, et al.
Menopause (New York, N.Y.)|February 4, 2011
Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trialGloria Bachmann, Uel Crosby, Robert A Feldman, et al.
Journal of Lower Genital Tract Disease|August 5, 2014
Milnacipran in provoked vestibulodynia: efficacy and predictors of treatment successCandace Brown, Gloria Bachmann, David Foster, et al.
Maturitas|May 13, 2015
The exercise prescription for enhancing overall health of midlife and older womenMiriam J Woodward, Chi Wei Lu, Richard Levandowski, et al.
The Journal of Reproductive Medicine|September 14, 2006
Subjective and objective outcomes of botulinum toxin type A treatment in vestibulodynia: pilot dataCandace S Brown, Howard I Glazer, Val Vogt, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 1, 2011
Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studiesLeena Anttila, Gloria Bachmann, László Hernádi, et al.
Contraception|August 25, 2004
Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenoneGloria Bachmann, Patricia J Sulak, Carole Sampson-Landers, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|January 10, 2009
Continued symptom improvement in sexually active women with overactive bladder and urgency urinary incontinence treated with tolterodine ER for 6 monthsRebecca G Rogers, Tola Omotosho, Gloria Bachmann, et al.
Pageof 11